Inside the protesters’ encampment at UCLA, beneath the glow of hanging flashlights and a deafening backdrop of exploding flash-bangs, OB-GYN resident Elaine Chan suddenly felt like a battlefield medic.
Kyverna surges after IPO, and CEO lays out plans for cell therapy in immune diseases
Kyverna Therapeutics started its first day as a public biotech on a strong note, with its shares $KYTX rising more than 50% Thursday afternoon after